Quanterix Corporation QTRX
1.96 USD -0.07 (-3.45%)
Regular-session close
1.96 0.00 0.00%
After hours · Nov 20, 4:26 PM ET
1.78 Day range 2.03
1.77 52-week range 8.77
- YTD
- -69.18%
- 1 year
- -66.84%
Benzinga news
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose…benzinga.com Quanterix Affirms FY2026 Sales Guidance of $142.000M-$146.000M vs $143.357M Est Quanterix (NASDAQ:QTRX) affirms FY2026 sales outlook from $142.000 million-$146.000 million to $142.000 million-$146.000 million vs $143.357 million estimate.
benzinga.com Quanterix Signs MoU With ALZAI Health To Explore Collaboration On Earlier Identification And Assessment Of Alzheimer's The proposed collaboration is intended to explore opportunities to combine ALZAI's AI-driven Alzheimer's disease risk identification technology with Quanterix's LucentAD® blood-based biomarkers, with…
benzinga.com TD Cowen Maintains Hold on Quanterix, Raises Price Target to $4 TD Cowen analyst Dan Brennan maintains Quanterix (NASDAQ:QTRX) with a Hold and raises the price target from $3.5 to $4.
benzinga.com Quanterix Q3 2026 Earnings Call Transcript Quanterix (NASDAQ:QTRX) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com Quanterix Q3 EPS $(0.46) Misses $(0.43) Estimate, Sales $34.974M Beat $33.853M Estimate Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.43) by 6.98 percent. This is a 36.99 percent increase over losses of $(0.73)…
benzinga.com Quanterix Narrows FY2026 Sales Guidance from $142.000M-$148.000M to $142.000M-$146.000M vs $143.357M Est Quanterix (NASDAQ:QTRX) narrows FY2026 sales outlook from $142.000 million-$148.000 million to $142.000 million-$146.000 million vs $143.357 million estimate.
